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Background Dislocation following total hip replacement (THR) is associated with repeated hospitalisations 
and substantial costs to the health system. Factors influencing dislocation following primary THR are not well 
understood. We aimed to assess the associations of patient-, surgery-, implant- and hospital-related factors 
with dislocation risk following primary THR. 
Methods We did a systematic review and meta-analysis of all longitudinal studies reporting these 
associations. We searched MEDLINE, Embase, Web of Science, and Cochrane Library to March 8, 2019. 
Summary measures of association were calculated using relative risks (RRs) (with 95% confidence intervals, 
CIs). The review is registered on PROSPERO, number CRD42019121378. 
Findings We identified 149 articles based on 125 unique studies with data on 4 633 935 primary THRs and 
35 264 dislocations. The incidence rates of dislocation ranged from 0·12% to 16·13%, with an overall pooled 
rate of 2·10% (1·83-2·38) over a weighted mean follow-up duration of 6 years. Using median year of data 
collection, there was a significant decline in dislocation rates from 1971 to 2015. Comparing males vs 
females, age ≥70 vs <70 years, and high vs low income, RRs (95% CIs) for dislocation were 0·97 (0·88-1·08), 
1·27 (1·02-1·57), and 0·79 (0·74-0·85) respectively. White ethnicity, drug use disorder, and social deprivation 
were each associated with an increased dislocation risk. Comparing body mass index (BMI) ≥30 vs. <30 
kg/m2, the RR (95% CI) for dislocation was 1·38 (1·03-1·85). Medical and surgical history-related factors 
associated with dislocation risk included neurological disorder, psychiatric disease, comorbidity indices, 
previous surgery including spinal fusion, and surgical indications including avascular necrosis, rheumatoid 
arthritis, inflammatory arthritis, and osteonecrosis. Surgical factors such as the anterolateral, direct anterior, or 
lateral approach and posterior with short external rotator and capsule repair were each associated with reduced 
dislocation risk. At the implant level, larger femoral head diameters, elevated acetabular liners, dual mobility 
cups, cemented fixations and standard femoral neck lengths reduced the risk of dislocation. Hospital-related 
factors such as experienced surgeons and high surgeon procedure volume each reduced the risk of dislocation. 
Interpretation Dislocation following primary THR is on a temporal decline. Surgical approaches that reduce 
dislocation risk can be used by clinicians when performing primary THR. Alternative bearings such as dual 
mobility can be used in individuals at high risk of dislocation. Modifiable risk factors such as high BMI and 
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Total hip replacement (THR) is a common, successful and cost-effective intervention for improving pain and 
disability associated with advanced hip joint disease such as osteoarthritis.1-4 Despite high success rates, some 
replacements inevitably fail. Common indications for revision after primary THR include aseptic loosening, 
dislocation, prosthetic joint infection, fracture, and adverse reaction to particulate debris.5 In 2017, of the 
8,589 revision procedures recorded in the National Joint Registry of England, Wales and Northern Ireland and 
the Isle of Man, 44% were for aseptic loosening, 16% for dislocation, 16% for infection and 15% for 
periprosthetic fracture.5 The incidence of dislocation has been reported to range from less than 1% to as high 
as 22%.6-11 More than half of dislocations occur in the first three months following primary THR.12-14 As the 
population ages and with growing volumes of primary THR, it is estimated that there will be a proportionate 
rise in the number of complications and revisions,15,16 including revision for dislocations. Dislocation can 
result in severe pain, restriction of mobility, recurrent dislocation, and poor quality of life.17 The associated 
consequences of dislocation include repeated hospitalisations and substantial financial burden to both patient 
and healthcare system.11,18 It has been reported that that an early dislocation increased the cost of a primary 
THR by 342%19 and a recurrent dislocation increased costs by 300% compared with an isolated episode of 
dislocation.17 
There is therefore a need to maximise the delivery of efficient and cost-effective healthcare. Hence, it 
is imperative to identify relevant factors which influence the risk of dislocation in order to counsel patients, 
guide surgeons and healthcare providers to plan effectively and mitigate risks. Data from revision THRs 
suggest that several patient-, surgery- and implant-related factors influence dislocation rates.20,21 Given the 
differing risk profiles, it is uncertain if these factors also apply to primary THR. Individual studies are not 
always definitive, as some are often poorly powered to adequately quantify the nature and magnitude of the 
associations and findings are not always inconsistent. Previous reviews on the topic have often only focused 
on single or a few risk factors, used narrative approaches to summarise the data or did not conduct detailed 
exploration of potential sources of bias such as heterogeneity and publication bias.22-26 Furthermore, several 
relevant individual studies have been published since the publication of these reviews. There is therefore a 
need for a comprehensive quantitative synthesis of the evidence in one single investigation, which will bring 




factors to disentangle any inconsistencies in the evidence. Given the existing evidence, we hypothesise that a 
wide range of patient-, surgery-, implant- and hospital-related factors will influence the risk of dislocation 
following primary THR. 
In the absence of data from a carefully designed and adequately powered large-scale study, we aimed 
to comprehensively assess the nature and magnitude of the longitudinal associations of patient-, surgery-, 
implant- and hospital-related factors with the risk of dislocation following primary THR by conducting a 
systematic meta-analysis of published studies. Given the variable incidence rates of dislocation reported in the 
literature,6-11  a secondary aim was to pool and characterise temporal trends in incidence rates of dislocation 
across identified studies. 
 
Methods 
This review was based on a pre-defined protocol which was registered in the prospective register of 
systematic reviews, PROSPERO (CRD42019121378) and was conducted in accordance with PRISMA and 
MOOSE guidelines27,28 (appendix pp 2-4). Detailed description of data sources and search strategy, eligibility 
criteria, and data extraction and quality assessment methods are reported in appendix pp 5-6. 
 
Statistical analyses 
We pooled the incidence rate for dislocation (estimated from the number of dislocations within average 
follow-up period/total number of participants or procedures as reported) with 95% confidence intervals (CIs). 
Temporal trends in dislocation rates were evaluated using the median year of data collection/surgery reported 
by studies, as previously reported.29 Relative risks (RRs) with 95% CIs were used as summary measures of 
associations. Detailed statistical analyses are described in appendix pp 9. The statistical analyses employed 
Stata MP 16 (Stata Corp, College Station, Texas, USA).   
 
Role of the funding source 
The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the 
manuscript. SKK had full access to all the data in the study and had final responsibility for the decision to 





The literature search strategy and manual screening of references identified 1145 potential articles relevant to 
the review. After screening of titles and abstracts, 271 articles remained for detailed full text evaluation. 
Following evaluation, 122 articles were excluded because (i) the exposure was not relevant or was assessed 
after THR (n=60); (ii) the population was not relevant (n=23); (iii) the outcome was not relevant (n=18); (iv) 
study design was not relevant (n=12); (v) full texts could not be retrieved (n=5); (vi) duplicate of another 
study already included in review (n=3); and (vii) no response to data request (n=1). The remaining 149 
articles corresponding to 125 unique studies were eligible to be included in the review (figure 1; table 1; 
appendix pp 11-20). 
The 125 unique studies comprised of 116 (92.8%) observational designs and 9 (7.2%) RCTs. 
Publication dates of included studies ranged from 1975 to 2019. A summary of the key characteristics of 
eligible studies is presented in table 1. Relevant baseline characteristics and quality assessment scores (for 
observational studies) of the individual articles/studies are summarised in appendix pp 21-25. Overall, the 125 
studies involved 4 633 935 primary THRs and 35 264 dislocations. The 116 observational studies included 4 
632 574 primary THRs and 35 223 dislocations. Altogether, the 9 RCTs comprised 1361 primary THRs and 
41 dislocations. Overall, 53 (42.4%) studies were conducted in Europe (Denmark, Finland, Norway, Sweden, 
France, Germany, Italy, Lithuania, Switzerland, The Netherlands, Spain, and UK), 52 (41.6%) in North 
America (USA and Canada), 15 (12.0%) in Asia (China, Japan, South Korea, and Taiwan), and 5 (4.0%) from 
the Pacific region (Australia). The average baseline age of participants in the included studies ranged from 
42·8 to 78·0 years and the weighted mean age was 66·4 years. The average duration of follow-up for 
dislocation outcomes reported by studies ranged from 5 days to 14 years, with a weighted mean follow-up 
duration of 6 years. Methodological quality of observational studies ranged from 5-8 using NOS.  Using the 
Cochrane risk of bias tool, 7 of 9 trials demonstrated a high risk of bias within 1-4 areas of study quality 
(blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, and other 
bias). All trials had a low risk of bias for selective reporting. Four trials had an unclear risk of bias in random 
sequence generation and allocation concealment. Two trials had a low risk of bias in all but one area of study 




Across 112 studies with relevant data over a weighted mean follow-up duration of 6 years, the 
incidence rates of dislocation ranged from 0·12% to 16·13%. The pooled random effects incidence rate (95% 
CI) over this follow-up duration was 2·10% (1·83-2·38) (appendix pp 27). The 95% prediction interval for the 
summary incidence rate was 0·25 to 5·41%, suggesting that the true incidence rate for any single new study 
will usually fall within this range. Comparing reported dislocation endpoints by case series and registries, the 
incidence rate of dislocation was 2·28% (1·93-2·66) over a weighted mean follow-up duration of 5·8 years 
and that for revision for dislocation was 0·88% (0·66-1·12) over a weighted mean follow-up duration of 6·5 
years. The pooled incidence rate of dislocation at specific average follow-up periods reported by studies was 
0·00% (0·00-0·00) at < 30 days (inpatient stay), 1·32% (1·14-1·50) at 30 days, 1·21% (0·97-1·48) at 3 
months, 1·91% (1·39-2·49) at 6 months, 2·12% (1·19-3·28) at 1 year, 1·99% (1·57-2·45) at 2 years, 1·76 
(1·52-2·02) at 5 years, and 3·60% (2·42-4·99) at 10 years (appendix pp 28). There was a decrease in 
dislocation rates from 1971 to 2015, based on the median year of data collection/surgery (figure 2A) and the 
decline was significant in a meta-regression analysis (p=0·016) (figure 2B). 
Figure 3 provides a summary of the associations of several sociodemographic characteristics and 
body mass index (BMI) with the risk of dislocation. Older age was associated with an increased risk of 
dislocation: RRs (95% CIs) of 1·27 (1·02-1·57) and 1·01 (1·00-1·03) comparing age ≥70 years vs <70 years 
(8 studies) and per one-year increase (7 studies) respectively. Comparing males with females in 30 studies, the 
pooled RR (95% CI) for dislocation was 0·97 (0·88-1·08) (figure 3; appendix pp 29). There was evidence of 
substantial heterogeneity between studies contributing gender data (I2 =80%; 95% CI 73, 86%; p<0·001), 
which was partly explained by degree of adjustment (p for meta-regression=0·044) and study methodological 
quality (p for meta-regression<0·001) (appendix pp 30). Comparing high to low income (5 studies), the 
pooled RR (95% CI) for dislocation was 0·79 (0·74-0·85). There was no difference in the risk of dislocation 
comparing public with private insurance/funding (4 studies); RR (95% CI) of 1·18 (0·87-1·58). Alcohol use 
disorder and smoking status were not associated with the risk of dislocation. Results from single reports 
showed that White race/Caucasians (compared to Asian race), social deprivation, drug use disorder and care 
in a skilled nursing facility (compared to care at home) after the surgery, were each associated with an 




The associations of BMI by specified categories with the risk of dislocation were reported in 22 
studies (figure 3; appendix pp 31). In pooled analysis of 14 studies, the RR (95% CI) for dislocation 
comparing BMI ≥30 vs <30 kg/m2 was 1·38 (1·03-1·85). There was evidence of heterogeneity between these 
contributing studies (I2 =64%; 95% CI 36, 80%; p=0·001), which was partly explained by the sample size (p 
for meta-regression=0·02) and methodological quality of studies (p for meta-regression<0·001)  (appendix pp 
32). The pooled RR (95% CIs) for dislocation in two studies comparing BMI ≥35 vs <35 kg/m2 was 1·05 
(1·01-1·10). Comparing BMIs ≥25 vs <25 and underweight vs normal weight, there were no significant 
associations. Findings from single reports showed that assessment of BMI as a continuous variable was not 
associated with an increased risk of dislocation per unit BMI increase, whereas comparing BMI ≥50 vs <50 
kg/m2 was associated with an increase in dislocation risk RR (95% CI) of 1·40 (1·31-1·50). A single study 
assessed the association between height and dislocation risk and reported a RR (95% CI) of 1·03 (0·98-1·07) 
per 1 cm increase in height. 
The associations of several medical and surgical history characteristics as well as surgical approaches 
with the risk of dislocation are reported in figure 4. In pooled analysis of 9 studies, a history of a neurological 
disorder was associated with an increased risk of dislocation RR (95% CI) 2·54 (1·86-3·48) (figure 4; 
appendix pp 33). In pooled analysis of 4 studies, a history of psychiatric disease was associated with an 
increased risk of dislocation, RR (95% CI) 1·35 (1·18-1·54) (figure 4). In single reports, there was evidence 
of statistically significant associations of dislocation with histories of frailty, chronic lung disease, renal 
failure, and rheumatoid disease whereas diabetes, neurodegenerative disease, and peripheral vascular disease 
were not associated. The following comorbidity indices comparisons: American Society of Anesthesiologists 
(ASA) grade 3-4 vs 1-2; ASA grade 2 vs 1; Charlson Comorbidity Index (CCI) 1 or more vs 0; and per unit 
increase in CCI, were each associated with an increase in risk of dislocation (figure 4). Comparing a previous 
spinal fusion vs none and previous surgery of the hip vs none, the RRs (95% CIs) for dislocation were 2·19 
(2·06-2·33) and 3·43 (1·45-8·13) respectively. In evaluation of surgical indications for primary THR, 
avascular necrosis (11 studies), rheumatoid arthritis (11 studies), inflammatory arthritis (7 studies), and 
osteonecrosis (5 studies) were each associated with an increased risk of dislocation when compared with 
osteoarthritis: RRs (95% CIs) of 1·71 (1·33-2·18), 1·94 (1·65-2·27), 1·45 (1·28-1·65) and 1·48 (1·11-1·97) 




for avascular necrosis and rheumatoid arthritis were (I2 =72%; 95% CI 49, 85%; p<0·001) and (I2 =19%; 95% 
CI 0, 59%; p=0·26) respectively. Study level characteristics such as geographical location, endpoint 
(dislocation vs revision for dislocation), and sample size seemed to be partly responsible for the substantial 
heterogeneity among studies contributing data for avascular necrosis (appendix pp 36). 
In pooled analyses of the following surgical approach comparisons: posterior vs anterolateral (15 
studies); direct anterior vs posterior (13 studies); and posterior vs lateral (9 studies), RRs (95% CIs) of 
dislocation were 2·00 (1·39-2·87); 0·57 (0·40-0·83); and 1·61 (1·17-2·21) respectively (figure 4). Between-
study heterogeneity estimates for studies contributing data for surgical approach comparisons: posterior vs 
anterolateral and direct anterior vs posterior were (I2 =90%; 95% CI 86, 93%; p<0·001) and (I2 =25%; 95% CI 
0, 61%; p=0·20) respectively (appendix pp 37-38). None of the study-level characteristics explored explained 
the substantial heterogeneity between studies contributing data for posterior vs anterolateral surgical 
approaches (appendix pp 39). Summary associations of other surgery-related factors with the risk of 
dislocation are reported in appendix pp 40. In pooled analysis of 12 studies that compared a posterior 
approach with short external rotator and capsule repair with no repair, the RR (95% CIs) for dislocation was 
0·28 (0·12-0·66) (appendix pp 40-41). There was evidence of heterogeneity between these contributing 
studies (I2 =60%; 95% CI 25, 79%; p=0·004), which was not explained by any of the study level 
characteristics evaluated (appendix pp 42). The following binary factors related to acetabular cup position 
were all associated with an increased risk of dislocation: cup abduction >50 or >55 degrees; cup abduction 
window 35 to 50 degrees / cup anteversion window 5 to 25 degrees; cup anteversion window 10 to 30 
degrees; and cup anteversion window 0 to 20 degrees (appendix pp 40). For combined stem and cup position, 
pooled analysis of two studies showed a combined window of 40 to 60 degrees was associated with an 
increased risk of dislocation RR (95% CIs) of 6·59 (1·98-21·93). Other factors such as femoral stem position, 
type of anaesthesia employed during surgery, and computer-assisted techniques were each not associated with 
the risk of dislocation (appendix pp 40).  
Fifty studies reported on associations between implant-related factors and the risk of dislocation 
(appendix pp 43). Comparing femoral head diameters 28mm vs 32mm; 22mm vs 32mm; 36mm vs 28mm; 
36mm vs 32mm; >36mm vs 28mm; 26mm vs 30mm; and 28mm vs 30mm, RRs (95% CIs) of dislocation 




4·40); and 1·76 (1·32-2·36) respectively. There was evidence of moderate heterogeneity between studies 
contributing data for the femoral head diameter comparison 28mm vs 32mm (12 studies; appendix pp 43-44) 
(I2 =61%; 95% CI 27, 79%; p=0·003), which was not explained by any of the study level characteristics 
evaluated (appendix pp 45). In single reports that evaluated acetabular cup outer diameter, RRs (95% CIs) of 
dislocation were 0·42 (0·21-0·86) and 3·43 (1·27-9·29) respectively for the comparisons: ≥56mm vs <56mm 
and ≥62mm vs ≤60mm. In pooled analysis of 4 studies, comparing an elevated acetabular liner with a 
standard rim, the RR (95% CIs) of dislocation was 0·49 (0·36-0·66). Six studies assessed the association 
between acetabular cup design and the risk of dislocation: compared to a conventional cup, a dual mobility 
cup was associated with a reduced risk of dislocation RR (95% CI) 0·15 (0·08-0·29). Cemented fixations 
were associated with a reduced risk of dislocation compared to uncemented fixations RR (95% CI) of 0·72 
(0·57-0·91). There was no evidence of associations of other fixation types (hybrid and reverse hybrid) with 
the risk of dislocation (appendix pp 43). In separate evaluation of acetabular and femoral fixation types, a 
cemented acetabular component fixation (vs uncemented) was associated with a reduced risk of dislocation 
RR (95% CI) of 0·63 (0·47-0·84); whereas a cemented femoral component fixation (vs uncemented) was not 
associated with dislocation risk. On the role of bearing types on the risk of dislocation, comparing metal-on-
metal (MoM) vs metal-on-polyethylene (MoPE); ceramic-on-cross-linked polyethylene (CoXLPE) vs metal-
on-cross-linked polyethylene (MoXLPE); and ceramic-on-ceramic (CoC) vs metal-on-cross-linked 
polyethylene (MoXLPE), RRs (95% CIs) were 2·44 (1·23-4·85); 0·79 (0·65-0·96); and 0·69 (0·54-0·88) 
respectively. On the influence of femoral neck length on dislocation risk, both long and short necks were each 
associated with an increased risk of dislocation when compared to standard neck; RRs (95% CIs) of 3·55 
(1·83-6·86) and 2·38 (1·02-5·56) respectively. Other factors relating to femoral stem type and design were 
each not associated with the risk of dislocation (appendix pp 43).  
A total of 13 studies reported on the associations of hospital-related factors and the risk of dislocation 
(appendix pp 46-47). There was a decreased risk of dislocation comparing experienced surgeons with less 
experienced surgeons in pooled analysis of 4 studies RR (95% CI) 0·66 (0·48-0·92). In pooled analysis of two 
studies, hospitals with high surgeon procedure volume were associated with a decreased risk of dislocation 
compared to low volume RR (95% CI) 0·31 (0·25-0·39). In a single study that assessed the influence of 




reduced risk of dislocation compared to nonparticipants RR (95% CI) 0·36 (0·14-0·92). Other assessed factors 
such as hospital location (urban vs rural), hospital type (teaching vs nonteaching), hospital procedure volume 
(high vs low), and hospital stay (short vs long stay) were each not associated with the risk of dislocation.  
Funnel plots for all comparisons that involved 10 or more studies were all symmetrical under visual 
examination (appendix pp 48). All results were consistent with Egger’s regression tests showing little 
evidence of publication bias. 
 
Discussion 
Over an average follow-up of 6 years, the incidence rates for dislocation following primary THR ranged from 
0·12 to 16·13% across individual studies and averaged approximately 2·10% in pooled analysis. Our results 
also showed a temporal decline in dislocation rates following primary THR. On the role of patient-related 
factors and their associations with the risk of dislocation, older patients, White ethnicity, high BMI, low 
income, drug use disorder, and social deprivation each had an increased risk of dislocation. Comorbidities that 
increased the risk of dislocation included neurological disorders, psychiatric disease, frailty, chronic lung 
disease, renal failure, and rheumatoid disease. High ASA grade or CCI was associated with an increased risk 
of dislocation. Patients with previous surgery such as spinal fusion and previous hip surgery also had an 
increased risk of dislocation. Patients undergoing THR for avascular necrosis, rheumatoid arthritis, 
inflammatory arthritis, or osteonecrosis were at increased risk of dislocation. At the surgical level, surgical 
approaches such as anterolateral, direct anterior, lateral or lateral with trochanteric osteotomy was associated 
with reduced risk of dislocation compared to the posterior approach. However, performing short external 
rotator and capsule repair with the posterior approach led to a lower risk of dislocation for this approach. At 
the implant level, larger femoral head diameters, elevated acetabular liners, dual mobility cups, cemented 
fixations, bearing types (MoPE, CoXLPE, CoC) or standard femoral neck lengths reduced the risk of 
dislocation. Hospital-related factors such as experienced surgeons, high surgeon procedure volume or 
preoperative patient education reduced the risk of dislocation.  
A number of previous reviews have attempted to investigate potential risk factors for dislocation in 
THR, but these have either been based on single or selected risk factors, revision THR, a mixture of both 




colleagues in their review sought to evaluate the influence of obesity; in pooled analysis of 10 out of 15 
studies, they demonstrated obesity (BMI >30 vs <30 kg/m2) to be associated with an increased risk of 
dislocation.22 In pooled analysis of 14 studies (of which 12 estimates were actually pooled), Jia and colleagues 
compared dislocation risk between direct anterior and posterior surgical approaches and reported no statistical 
significant difference in risk and their estimate was imprecise because of the low event rate.23 In our pooled 
analysis of 13 studies, the direct anterior approach was associated with a substantial risk reduction in 
dislocation compared with the posterior approach. However, the summary effect estimate seemed to be driven 
by the largest study included in the analysis;32 hence, further studies are required to confirm this finding. In 
pooled analysis of seven clinical trials using a posterior approach for primary THR, use of a soft tissue repair 
was associated with a reduced risk of dislocation.31 Consistent with our findings of reduced risk of 
dislocations with dual mobility bearing surfaces (compared with standard bearings) and larger femoral head 
sizes, a recently published network meta-analysis demonstrated similar findings but was based on primary or 
revision THRs.30 To our knowledge, our review represents the first attempt at evaluating and synthesising 
evidence on the relationships of patient-, surgery-, implant- and hospital-related factors with dislocation risk 
in one single investigation and in more detail than ever before using a systematic meta-analytic approach. 
Several plausible underlying pathways may explain some of the associations demonstrated. The role 
of gender in relation to complications and implant failure following THR is a controversial topic. Similarly, 
evidence on the role of gender in influencing dislocation has been inconsistent; whereas some studies have 
reported increased dislocation risk for females,6,33 others have reported opposite findings.34,35 Overall, our 
findings suggest that gender may not be an independent risk factor for dislocation following primary THR. 
The increased risk of dislocation associated with low income and social deprivation is likely to be 
multifactorial. However, there is a possibility that these patients have lower levels of education, have poorer 
access to specialised care and are more likely to be referred to less-experienced surgeons. Whether obesity 
(compared to normal weight) as measured by BMI, influences the risk of dislocation following THR has also 
been a subject of controversy,22 as findings from studies have been contradictory and plausible explanations 
have been proposed for these inconsistent findings. For example, it has been suggested that obesity is 
associated with limited mobility and hence less risk of complications such as dislocation, since these 




indeed be associated with an increased risk of dislocation. Plausible pathways underlying this relationship 
include the presence of more comorbidities, component malpositioning and less stability in the early 
postoperative period; the latter arising from greater soft tissue damage and the longer duration of surgery 
associated with a larger soft tissue envelope.22,37,38 Extraarticular impingement created by thigh-on-thigh soft 
tissue contact during adduction and flexion, is also more prevalent in higher BMIs leading to the femoral head 
lifting out of the acetabular cup.39 Several comorbidities such as neurological disorders, psychiatric diseases, 
frailty and renal failure were associated with increased dislocation risk; which are likely due to factors 
associated with these conditions such as muscle weakness, imbalance, and inability to comply with activity 
restrictions and are known to increase the risk of dislocation.40-42 It has been postulated that the increased 
dislocation risk associated with spinal fusion is because these patients often have less pelvic roll when seated 
with more hip flexion, which leads to less acetabular component anteversion and increased dislocation when 
they stand from sitting.43 Though computer-assisted surgery has been developed to help orthopaedic surgeons 
achieve better accuracy of implant placement (e.g., cup placement) and to improve functional outcomes and 
reduce complications such as dislocation, risk estimates from the one study that evaluated this33 found no 
significant difference in dislocation risk comparing computer-assisted THR with conventional THR. These 
findings are consistent with two other studies,44,45 though they could not be included in our pooled analysis 
because risk estimates for dislocation risk were not available. Though computer-assisted surgical techniques 
improve cup position in THR surgery46 and are increasingly being adopted by surgeons,47 little evidence exists 
to show they actually improve outcomes and reduce complication rates in total joint replacement.44,45,48,49   
In the United States, it has been estimated that there will be an increase in the demand of primary 
THRs by 174% between 2005 and 2030.15 Dislocations, which are also common causes of revision surgery,5 
are therefore expected to rise proportionately. The social, health and economic costs associated with 
dislocations are substantial and potentially devastating.11,18 Our review has demonstrated that the aetiology of 
dislocation is multifactorial and can be attributed to patient-, surgery-, implant- and hospital-related factors, 
the majority of which are modifiable or there are strategies available to ameliorate the associated risks. 
Recognition of these factors prior to surgery with careful planning before and after surgery may represent an 




In addition to several strengths already mentioned, our review is the first comprehensive assessment 
of the incidence of dislocation following primary THR with characterisation of temporal trends. Included 
studies were based on patients from many continents which made results generalisable. We employed 
appropriate meta-analytic approaches in our analyses; these included standardisation and harmonisation of 
some reported associations to a common scale to ensure consistency before pooling, quantification and 
exploration of heterogeneity, and evaluation of small study effects. Finally, given that some of the articles 
were based on the same database or study and therefore presented the potential for participant overlap, we 
employed comprehensive data checks to ensure the uniqueness of each study in contributing data to the 
pooled analysis and therefore it is unlikely any patients would have been double counted during the pooling 
process. Several limitations deserve consideration; (i) inability to characterise the shape of any dose-response 
associations due to lack of appropriate data; (ii) lack of consistent reporting precluded exploration of 
associations by whether dislocation was early or late; (iii) the majority of studies were retrospective in design 
and also did not adjust for confounding; (iv) given the use of published data, we were unable to account for 
temporal changes in risk factors due to recent innovations in THR or adoption of strategies to mitigate the risk 
of dislocation; (v) our findings on the temporal trends in dislocation rates were based on median year of data 
collection reported by studies, which may not accurately capture specific periods of surgery and follow-up; 
(vi) our incidence data at specific time points were based on average follow-up periods reported by eligible 
studies, hence these findings may be underestimates and finally (vii) some of our findings were based on 
single reports, hence they need interpretation with caution and also require replication in further studies. 
In conclusion, this aggregate review demonstrates that though the incidence of dislocation following 
primary THR is variable, the average incidence is less than 3% over an average follow-up period of 6 years 
and there is a temporal decline in rates. The risk of dislocation following primary THR has a multifactorial 
aetiology. Surgical approaches that reduce dislocation risk should be preferred in primary THR. For patients 
at high risk of dislocation, use of cemented fixations, large femoral head sizes, elevated acetabular liners or 
dual mobility bearings may be considered. Modifiable risk factors such as high BMI and comorbidities should 
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Research in context 
Evidence before this study 
Dislocation is a common indication for revision following primary total hip replacement 
(THR) and is associated with severe pain, restriction of mobility, recurrent dislocation, poor 
quality of life and substantial healthcare costs. There is therefore an urgent need to identify 
relevant factors which influence the risk of dislocation in order to counsel patients, guide 
surgeons and healthcare providers to plan effectively and mitigate risks. Data from several 
individual longitudinal studies conducted in revision THRs as well as their aggregate analyses, 
suggest that several patient- (demographics and comorbidity), surgery- (approach) and 
implant-related factors (bearing size and component position) influence dislocation rates. It is 
uncertain if these factors also apply to primary THR. In a preliminary literature search, we 
searched MEDLINE, Embase and Web of Science from inception to February 5, 2019, for 
systematic reviews and meta-analyses reporting on associations of patient-, surgery-, implant- 
or healthcare system-related factors with risk of dislocation following primary THR. We used 
search terms related to the population (e.g., “primary total hip replacement”), exposures (e.g, 
“risk factor”, “body mass index”, “comorbidity”), and outcome (e.g., “dislocation”, 
“instability”). Majority of reviews identified were based on revision THRs. Five relevant 
reviews attempted to investigate potential risk factors for dislocation in primary THR, but 
these were based on single or selected risk factors (mostly comorbidities), included a mixture 
of both primary and revision THRs, summarised the evidence using a narrative approach or 
did not explore for potential sources of bias. No review has comprehensively and 
quantitatively evaluated evidence on the role of patient-, surgery-, implant- or healthcare 
system-related factors on dislocation risk following primary THR. Variable incidence rates of 
dislocation are also reported in the literature. 
Added value of this study 
To our knowledge, this is the first aggregate analysis to evaluate the associations of several 




incidence of and temporal trends in dislocation following primary THR in one single 
comprehensive investigation. In contrast to previous individual studies and reviews, these 
findings provide a detailed picture of the multifactorial aetiology of dislocation risk following 
primary THR. Though multifactorial, it appears most of the risk is driven by patient factors 
(such as sociodemographic characteristics, high body mass index, and comorbidities), surgery-
related factors (surgical approaches) and several implant-related factors. Except for surgeon 
experience and high surgeon procedure volume which decrease the risk of dislocation, the 
majority of hospital-related factors do not seem to influence the risk of dislocation. Over an 
average follow-up period of 6 years, the average incidence of dislocation following primary 
THR is less than 3%. Furthermore, there appears to be an ongoing worldwide temporal decline 
in dislocation rates following primary THR, which likely reflects recent innovations in 
surgical practice. 
Implications of all the available evidence 
As life expectancy continues to increase with a growing burden due to osteoarthritis, there will 
be an increase in demand for primary THRs and dislocations are expected to increase 
proportionately. The social, health and economic costs associated with dislocations are 
substantial and potentially devastating. This study demonstrates that the risk of dislocation can 
be attributed to several patient-, surgery-, implant- and hospital-related factors, the majority of 
which are modifiable or there are strategies available to ameliorate the associated risks. 
Recognition of these factors prior to surgery with careful planning before and after surgery and 
using a multidisciplinary approach may represent an implementable strategy by which 
dislocations can be prevented or minimised among patients at high risk. Furthermore, data on 
incidence rates and temporal trends of dislocation is a valuable resource for clinicians and 
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Figure 1. PRISMA flow diagram 
1145 Potentially relevant citations identified
From MEDLINE, Embase, Web of Science, 
Cochrane Library, and reference list of 
relevant studies
874 excluded on the basis of title 
and/ or abstract
122 Articles excluded due to:
60 Exposure not relevant
23 Population not relevant
18 Outcome not relevant
12 Study design not relevant
5 Full texts not retrievable
3 Duplicates
1 No response to data request
149 Articles included, based on 125 
unique studies
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A, Incidence of dislocation by median year of data collection; B, Meta-regression bubble plot of incidence of 







Figure 3. Associations of sociodemographic characteristics and body mass index comparisons with risk of 
dislocation 
Age
Age ≥70 years vs <70 years
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Figure 4. Associations of medical and surgical history comparisons and surgical approaches with risk of 
dislocation 
Comorbidity
Neurological disorder vs None
Psychiatric disease vs None
Diabetes vs None
Neurodegenerative disease vs None
Chronic lung disease vs None
Frailty vs None
Peripheral vascular disease vs None
Renal failure vs None
Rheumatoid disease vs None
Comorbidity indices
ASA grade 3-4 vs 1-2
ASA grade 2 vs 1
ASA grade 3 vs 1
ASA grade 4 vs 1
Charlson index score 1 or more vs 0
Per unit increase in Charlson index score
Surgical history
Spinal fusion vs None
Previous surgery vs None
Anterior rotational osteotomy vs None
Periacetabular osteotomy vs Rotational acetabular osteotomy
Indication for THR
Avascular necrosis vs OA
Rheumatoid arthritis vs OA
Inflammatory arthritis vs OA
Post-traumatic arthrtis vs OA
Osteonecrosis vs OA
Other vs OA
Perthe's disease vs OA
Ankylosing spondylitis vs OA
Secondary vs Primary OA
Surgical approach
Posterior vs Anterolateral




MI posterior vs Standard posterior
MI lateral/posterior vs Direct lateral
MI anterior/anterolateral vs Direct lateral
Learning curve (posterior to anterior) vs Posterior
Lateral with TO vs Lateral without TO
Lateral vs Anterolateral or straight lateral
2-incision vs Mini-posterior
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ASA, American Society of Anaesthesiologists; CI, confidence interval (bars); OA, osteoarthritis; RR, relative 








Total number of total hip replacements 4 633 935 
Total number of dislocation cases 35 264 
Study characteristics  
Location Number of studies (%) (Number of THRs) 
    North America 52 (41.6%) (3 216 656) 
    Asia 15 (12.0%) (14 691) 
    Europe 53 (42.4%) (1 000 150) 
    Pacific 5 (4.0%) (402 438) 
Study design Number of studies (%) (Number of THRs) 
    Retrospective cohorts 82 (65.6%) (4 151 752) 
    Prospective cohorts 28 (22.4%) (476 674) 
   Nested case-control studies 6 (4.8%) (4148) 
    Randomised controlled trials 9 (7.2%) (1361) 
Weighted mean follow-up (SD; min-max), years 5·96 (4.25; 0·05-14·00) 
Median (IQR) study quality score for observational studies 7 (6-8) 
Study level participant characteristics  
Weighted mean age (SD; min-max), years 66·4 (1.7; 42·8-78·0) 
Median (IQR) % males 44·0% (37·3-47·0) 
 
IQR=interquartile range; SD, standard deviation; THR, total hip replacement 
 
 
 
 
 
 
 
 
  
 
